A case of Ventricular Tachycardia and Cardiac Arrest Associated with Sertraline and Mirtazapine Combination
,
Abstract
A 67-year-old male suffering from depressive symptomatology was admitted to the inpatient clinic at Firat University School of Medicine; and his psychiatric evaluation revealed major depressive episode according to DSM-IV. He developed chest discomfort, chest pain and shortness of breath of acute onset accompanying pulseless ventricular tachycardia (VT) leading to cardiac arrest following sertraline and mirtazapine combination treatment. He died after two days in the Intensive Care Unit. The present case suggests that psychiatrists should be aware of unexpected cardiac events, especially when they use combination treatments.
Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH, et al. Sudden death in psychiatric patients. Br J Psychiatry 1998; 172: 331-336.
Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, Jr., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709.
Politi P, Piccinelli M, Klersy C, Madini S, Segagni LG, Fratti C, et al. Mortality in psychiatric patients 5 to 21 years after hospital admission in Italy. Psychol Med 2002; 32: 227-237.
Hannerz H , Borga P. Mortality among persons with a history as psychiatric inpatients with functional psychosis. Soc Psychiatry Psychiatr Epidemiol 2000; 35: 380-387.
Guy W. CGI (Clinical Global Impression). ECDEU Assessment Manual for Psychopharmacology – Revised (DHEW Publ No ADM 76-338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research, 1976, 218-222.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
Idle JR. The heart of psychotropic drug therapy. Lancet 2000; 355: 1824-1825.
Fisch C, Knoebel SB. Electrocardiographic findings in sertraline depression trials. Drug Invest 1992; 4: 305–312.
Fabre LF, Abuzzahab FS, Amin M, Claghorn JL, Mendels J, Petrie WM, et al. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 1995; 38: 592-602.
Glassman AH. Clinical management of cardiovascular risks during treatment with psychotropic drugs. J Clin Psychiatry 2002; 63 Suppl 9: 12-17.
Amin M, Lehmann H , Mirmiran J. A double-blind, placebo-controlled dose-finding study with sertraline. Psychopharmacol Bull 1989; 25: 164-167.
| Files | ||
| Issue | Vol 9 No 1 (2014) | |
| Section | Articles | |
| Keywords | ||
| Cardiac arrest Mirtazapine Sertraline | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
